tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market

Coya Therapeutics, Inc. (COYA) Financial Statements

Compare
65 Followers

Coya Therapeutics, Inc. Financial Overview

Coya Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.719; its P/E ratio is ―; Coya Therapeutics, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 6.00M$ 0.00$ 0.00$ 0.00
Gross Profit$ 5.97M$ -27.36K$ -16.13K$ 0.00
Operating Income$ -7.90M$ -9.81M$ -4.87M$ -694.77K
EBITDA$ -7.90M$ -12.22M$ -4.85M$ 10.44K
Net Income$ -7.99M$ -14.68M$ -4.87M$ -733.20K
Balance Sheet
Cash & Short-Term Investments$ 32.63M$ 5.93M$ 4.34M$ 8.72M
Total Assets$ 41.26M$ 8.40M$ 4.79M$ 8.75M
Total Debt$ 0.00$ 12.97M$ 0.00$ 0.00
Net Debt$ -32.63M$ 7.03M$ -4.34M$ -8.72M
Total Liabilities$ 5.63M$ 16.79M$ 1.15M$ 447.12K
Stockholders' Equity$ 35.64M$ -8.39M$ 3.64M$ 8.30M
Cash Flow
Free Cash Flow$ -11.19M$ -7.24M$ -4.04M$ -391.27K
Operating Cash Flow$ -11.19M$ -7.24M$ -3.90M$ -391.27K
Investing Cash Flow$ -543.19K$ -525.00K$ -136.80K$ 0.00
Financing Cash Flow$ 38.43M$ 9.36M$ -340.58K$ 9.11M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Coya Therapeutics, Inc. Debt to Assets

Coya Therapeutics, Inc. Cash Flow

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis